Gelidium elegans Regulates Blood Glucose Homeostasis in ICR Mice

Abstract

Gelidium elegans has been reported to improve metabolic function, but it has not been studied in non-obese mice with glucose tolerance. To evaluate the effect of Gelidium elegans (50 or 200 mg/kg doses) on glucose homeostasis, an oral glucose tolerance test (OGTT), oral maltose tolerance test (OMTT), and insulin tolerance test (ITT) were performed. The non-obese group of mice that was administered 200 mg/kg Gelidium elegans had significantly lowered blood glucose levels. By revealing that Gelidium elegans may improve glucose homeostasis, this study expands our understanding of the anti-diabetic effect of Gelidium elegans and its biological importance.